封面
市场调查报告书
商品编码
1535746

阿拉伯木聚醣纤维市场规模- 按应用(药品、饮料、食品、动物营养[[宠物、家禽、反刍动物、猪]])、按来源(大麦、大米、玉米、燕麦、小麦)和预测,2024 - 2032 年

Arabinoxylan Fiber Market Size - By Application (Pharmaceutical, Beverages, Food, Animal Nutrition [[Pet, Poultry, Ruminants, Swine]]), By Source (Barley, Rice, Maize, Oats, Wheat) & Forecast, 2024 - 2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 180 Pages | 商品交期: 2-3个工作天内

价格
简介目录

由于食品中天然和植物组成的趋势不断增长,2024年至2032年全球阿拉伯木聚醣纤维市场的复合年增长率将超过8.5%。

消费者越来越意识到天然纤维对健康的益处,包括它们在增强消化健康和支持健康方面的作用。随着越来越多的人寻求更健康和永续的食物选择,对阿拉伯木聚醣纤维的需求不断增加。更广泛的清洁标籤和最低限度加工食品运动正在鼓励餐饮企业投资研发并引入新原料,进一步推动市场成长。例如,2024 年 2 月,Ingredion 推出了 NOVATION(R) Indulge 2940,这是一种清洁标籤、非基因改造淀粉,可增强乳製品和植物性产品的胶凝和口感。这项创新提供了一种以玉米为基础的天然替代品,满足了注重健康的消费者对口感的需求。

整个阿拉伯木聚醣纤维市场根据应用、来源和地区进行分类。

由于其固有的功能优势和增强的营养成分,小麦细分市场从 2024 年到 2032 年将出现显着的复合年增长率。随着消费者和製造商优先考虑全谷物和富含纤维的食品,添加阿拉伯木聚醣的小麦产品可改善健康特性,例如更好的消化健康和血糖控制。有利于高纤维饮食的营养趋势导致对小麦阿拉伯木聚醣纤维的需求不断增长。

在阿拉伯木聚醣纤维的潜在治疗应用和健康益处的推动下,到 2032 年,药品领域将占据显着的市场份额。随着製药公司探索药物配方的天然和植物成分,该产品在增强药物传输系统和提高生物利用度方面的作用变得非常重要。它用于开发膳食补充剂和功能性食品,提供免疫支持和肠道健康等健康益处。在药品中加入更多天然成分的转变符合消费者对整体健康解决方案的偏好,该领域的需求不断增长。

由于人们越来越关注健康和保健趋势,欧洲阿拉伯木聚醣纤维市场从 2024 年到 2032 年将呈现强劲的复合年增长率。欧洲消费者正在寻求天然和永续的饮食解决方案,并偏好具有健康益处且源自可再生资源的纤维。对在食品和补充剂中加入有益纤维的监管支持鼓励采用阿拉伯木聚醣纤维。再加上消费者对此产品作用的认知不断提高,将有利于欧洲市场的成长。

目录

第 1 章:方法与范围

第 2 章:执行摘要

第 3 章:产业洞察

  • 产业生态系统分析
    • 主要製造商
    • 经销商
    • 全行业利润率
  • 产业影响力
    • 成长动力
      • 由于贸易情势积极,原材料供应成本低廉
      • 增加烘焙应用中的产品使用量
      • 膳食纤维市场快速扩张,国庆庆典更受到关注
    • 市场挑战
      • 过量膳食纤维的有害影响以及多样化的药品法规
    • 市场机会
      • 新机会
      • 成长潜力分析
  • 原料景观
    • 製造趋势
    • 技术演进
      • 永续製造
        • 绿色实践
        • 脱碳
    • 原材料的可持续性
    • 价格趋势(美元/吨)
  • 法规和市场影响
  • 波特的分析
  • PESTEL分析

第 4 章:竞争格局

  • 公司市占率分析
  • 竞争定位矩阵
  • 战略展望矩阵

第 5 章:市场规模与预测:按来源划分,2021-2032 年

  • 主要趋势
  • 小麦
  • 大麦
  • 燕麦
  • 玉米
  • 其他的

第 6 章:市场规模与预测:按应用划分,2021-2032 年

  • 主要趋势
  • 食物
    • 麵包店
    • 早餐麦片和零食
    • 糖果点心
    • 乳製品
    • 肉製品
    • 婴儿食品
  • 饮料
  • 製药
  • 动物营养
    • 反刍动物
    • 家禽
    • 宠物
  • 其他(个人护理和化妆品)

第 7 章:市场规模与预测:按地区划分,2021-2032 年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 亚太地区其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地区
  • MEA
    • 沙乌地阿拉伯
    • 阿联酋
    • 南非
    • MEA 的其余部分

第 8 章:公司简介

  • Shandong Zhi Shang Chemical Co. Ltd
  • Nanjing Raymon Biotech Co., Ltd
  • Acetar Bio-tech Inc
  • Triumph International Development Limited
  • Daiwa Pharmaceutical
  • Megazyme
  • Antimex Pharmaceuticals & Chemicals Ltd
  • Comet Biorefining
  • Cargill
  • Kowa India Pvt. Ltd
  • J. Rettenmaier & Sohne GmbH & Co. K
  • HL Agro
  • BioActor BV
简介目录
Product Code: 4656

Global Arabinoxylan Fiber Market will record over 8.5% CAGR from 2024 to 2032, owing to the growing trend towards natural and plant-based ingredients in food products.

There is an increase in consumer awareness of the health benefits associated with natural fibers, including their role in enhancing digestive health and supporting wellness. As more individuals seek healthier and sustainable food options, the demand for arabinoxylan fiber escalates. The broader movement towards clean labels and minimally processed foods is encouraging the F&B players to invest in R&D and introduce new ingredients, further propelling the market growth. For instance, in February 2024, Ingredion launched NOVATION(R) Indulge 2940, a clean-label, non-GMO starch enhancing gelling and mouthfeel in dairy and plant-based products. This innovation offers a natural, corn-based alternative, meeting the demands of health-conscious consumers for indulgent textures.

The overall arabinoxylan fiber market is sorted based on application, source, and region.

The wheat segment will witness a noteworthy CAGR from 2024 to 2032, due to its inherent functional benefits and enhanced nutritional profile. As consumers and manufacturers prioritize whole grain and fiber-rich foods, wheat products fortified with arabinoxylan offer improved health attributes, such as better digestive health and glycemic control. The nutritional trends favoring high-fiber diets contribute to the rising demand for wheat-based arabinoxylan fiber.

The pharmaceuticals segment will capture a notable market share by 2032, driven by the potential therapeutic applications and health benefits of arabinoxylan fiber. As pharmaceutical companies explore natural and plant-based ingredients for drug formulations, the product's role in enhancing drug delivery systems and improving bioavailability becomes significant. It is used in developing dietary supplements and functional foods, offering health benefits such as immune support and gut health. The shift towards incorporating more natural components in pharmaceutical products aligns with consumer preferences for holistic health solutions, thriving demand in the segment.

Europe arabinoxylan fiber market will demonstrate a strong CAGR from 2024 to 2032, owing to a growing focus on health and wellness trends. Consumers in Europe are seeking natural and sustainable dietary solutions, aligning with a preference for fibers that offer health benefits and are derived from renewable sources. The regulatory support for incorporating beneficial fibers in food and supplements is encouraging the adoption of arabinoxylan fiber. This, combined with heightened consumer awareness of the product's role, will favor the market growth in Europe.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Base estimates & calculations
  • 1.3 Forecast calculation
  • 1.4 Data sources
    • 1.4.1 Primary
    • 1.4.2 Secondary
      • 1.4.2.1 Paid sources
      • 1.4.2.2 Public sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
    • 3.1.1 Key manufacturers
    • 3.1.2 Distributors
    • 3.1.3 Profit margins across the industry
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Low cost raw material availability due to positive trade scenario
      • 3.2.1.2 Increasing product usage in bakery application
      • 3.2.1.3 Rapid expansion in dietary fibers market along with enhanced focus on NDP
    • 3.2.2 Market challenges
      • 3.2.2.1 Harmful effect of excessive dietary fiber along with diverse pharmaceutical regulations
    • 3.2.3 Market opportunity
      • 3.2.3.1 New opportunities
      • 3.2.3.2 Growth potential analysis
  • 3.3 Raw material landscape
    • 3.3.1 Manufacturing trends
    • 3.3.2 Technology evolution
      • 3.3.2.1 Sustainable manufacturing
        • 3.3.2.1.1 Green practices
        • 3.3.2.1.2 Decarbonization
    • 3.3.3 Sustainability in raw materials
    • 3.3.4 Pricing trends (USD/Ton)
      • 3.3.4.1 North America
      • 3.3.4.2 Europe
      • 3.3.4.3 Asia Pacific
      • 3.3.4.4 Latin America
      • 3.3.4.5 Middle East & Africa
  • 3.4 Regulations & market impact
  • 3.5 Porter's analysis
  • 3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Company market share analysis
  • 4.2 Competitive positioning matrix
  • 4.3 Strategic outlook matrix

Chapter 5 Market Size and Forecast, By Source, 2021-2032 (USD Million, Tons)

  • 6.1 Key trends
  • 6.2 Wheat
  • 6.3 Rice
  • 6.4 Barley
  • 6.5 Oats
  • 6.6 Maize
  • 6.7 Others

Chapter 6 Market Size and Forecast, By Application, 2021-2032 (USD Million, Tons)

  • 5.1 Key trends
  • 5.2 Food
    • 5.2.1 Bakery
    • 5.2.2 Breakfast cereals & snacks
    • 5.2.3 Confectionery
    • 5.2.4 Dairy
    • 5.2.5 Meat products
    • 5.2.6 Infant food
  • 5.3 Beverages
  • 5.4 Pharmaceutical
  • 5.5 Animal nutrition
    • 5.5.1 Swine
    • 5.5.2 Ruminants
    • 5.5.3 Poultry
    • 5.5.4 Pet
  • 5.6 Others (personal care & cosmetics)

Chapter 7 Market Size and Forecast, By Region, 2021-2032 (USD Million, Tons)

  • 7.1 Key trends
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 France
    • 7.3.4 Italy
    • 7.3.5 Spain
    • 7.3.6 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 India
    • 7.4.3 Japan
    • 7.4.4 South Korea
    • 7.4.5 Australia
    • 7.4.6 Rest of Asia Pacific
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Mexico
    • 7.5.3 Argentina
    • 7.5.4 Rest of Latin America
  • 7.6 MEA
    • 7.6.1 Saudi Arabia
    • 7.6.2 UAE
    • 7.6.3 South Africa
    • 7.6.4 Rest of MEA

Chapter 8 Company Profiles

  • 8.1 Shandong Zhi Shang Chemical Co. Ltd
  • 8.2 Nanjing Raymon Biotech Co., Ltd
  • 8.3 Acetar Bio-tech Inc
  • 8.4 Triumph International Development Limited
  • 8.5 Daiwa Pharmaceutical
  • 8.6 Megazyme
  • 8.7 Antimex Pharmaceuticals & Chemicals Ltd
  • 8.8 Comet Biorefining
  • 8.9 Cargill
  • 8.10 Kowa India Pvt. Ltd
  • 8.11 J. Rettenmaier & Sohne GmbH & Co. K
  • 8.12 HL Agro
  • 8.13 BioActor BV